Clinical Trials Browser

Phase 1/2 × Esophageal Neoplasms × S 1 (combination) × Clear all

NCT03991104 2023-09-21

SOX-based CRT for Esophageal Cancer.

Phase 1/2 Withdrawn

Gastrointestinal

Esophageal Neoplasms